Cost-of-illness trajectories among people with multiple sclerosis by comorbidity: A register-based prospective study in Sweden.

Greta BütepageAhmed EsawiKristina AlexandersonEmilie FribergChantelle MurleyJan HillertKorinna Karampampa

Published in: Multiple sclerosis journal - experimental, translational and clinical (2020)

High COI and heterogeneity in COI trajectories could be partly explained by the presence of chronic comorbidities in the year around MS diagnosis, including the presence of mental comorbidity.

Keyphrases

multiple sclerosis
depressive symptoms
mass spectrometry
white matter
mental health
single cell
ms ms